Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.

Publication Year: 2021

DOI:
10.1007/s00261-021-03378-0

PMCID:
PMC8847161

PMID:
34932163

Journal Information

Full Title: Abdom Radiol (NY)

Abbreviation: Abdom Radiol (NY)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestPerspectum Ltd. (Oxford, United Kingdom) provided in-kind support in the form of image post-processing for this study. Drs. Jonathan R. Dillman and Andrew T. Trout have received grant support from Perspectum Ltd, Siemens Medical Solutions, and Canon Medical Systems. Dr. Dillman has also received in-kind research support from Resoundant, Inc. and Philips Healthcare. No other authors have conflicts of interest to report. Ethical approvalThe study was performed in a manner compliant with the Health Insurance Portability and Accountability Act (HIPAA, USA) and was approved by the institutional review board. Consent to participateInformed consent was obtained from all participants, and informed assent was obtained as appropriate. Conflict of interest Perspectum Ltd. (Oxford, United Kingdom) provided in-kind support in the form of image post-processing for this study. Drs. Jonathan R. Dillman and Andrew T. Trout have received grant support from Perspectum Ltd, Siemens Medical Solutions, and Canon Medical Systems. Dr. Dillman has also received in-kind research support from Resoundant, Inc. and Philips Healthcare. No other authors have conflicts of interest to report."

Evidence found in paper:

"Funding Partial financial support was received from the Cincinnati Children’s Hospital Medical Center’s (CCHMC) (1) Center for Autoimmune Liver Disease and (2) Center for Translational Fibrosis Research."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025